Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response - Wikidata - awgldk - TriplyDB

Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response

Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response

http://www.wikidata.org/entity/Q37105363

about

Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease Adipose tissue macrophages: going off track during obesity Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea Metabolic syndrome and renal cell carcinoma The role of adipokines in chronic inflammation Hypoxia, Oxidative Stress and Fat Adipose tissue as a potential source of hematopoietic stem/progenitor cells (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights Human obesity and endothelium-dependent responsiveness Inflammation, obesity, and the promise of immunotherapy for metabolic disease Regulation of stem cell differentiation in adipose tissue by chronic inflammation The Circulatory and Metabolic Responses to Hypoxia in Humans - With Special Reference to Adipose Tissue Physiology and Obesity Adipose tissue dysfunction and its effects on tumor metabolism The cell biology of fat expansion The impact of high-intensity interval training versus moderate-intensity continuous training on vascular function: a systematic review and meta-analysis Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial Winning a Won Game: Caffeine Panacea for Obesity Syndemic Adipokines in inflammation and metabolic disease Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management.Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body.Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome Quantitative relationship between the octanol/water partition coefficient and the diffusion limitation of the exchange between adipose and blood.Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality.Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss Adipose tissue collagen VI in obesity.Upregulation of Early and Downregulation of Terminal Pathway Complement Genes in Subcutaneous Adipose Tissue and Adipocytes in Acquired Obesity.Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity.Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction Vascular inflammation in obesity and sleep apnea.Iron elevation and adipose tissue remodeling in the epididymal depot of a mouse model of polygenic obesity.Pioglitazone treatment reduces adipose tissue inflammation through reduction of mast cell and macrophage number and by improving vascularity.Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity.Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone Reduced oxygenation in human obese adipose tissue is associated with impaired insulin suppression of lipolysis.Chronic inflammation in obesity and the metabolic syndrome.Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysis.Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes.

P2860

Q26747585-00F6BC14-B9F7-4A75-9FDD-D808AFBA577A Q26748713-0BB4B9BC-F87D-4172-9501-D3983CD675AB Q26768692-5685611E-1548-432D-973E-FB164D6E4421 Q26775794-C4A8C732-28B4-4F77-B5DD-9ED5D8409CFE Q26783727-08FD7EB1-6345-4DCE-8E62-95D3D2F472CE Q26825147-0BD5CD87-9651-4EE0-8AEB-1730D9F7634C Q26852901-E12EE292-F4F7-46F9-8A81-AC7CC5B06FF8 Q26861253-A8CC7E92-4103-4ED7-BD11-7C5D7E3EB2ED Q26991965-4B8BE28D-BBD5-4046-BC65-9F820B27B873 Q27013554-B5D84DE2-0F5E-4DC4-836E-3248BD2181D1 Q27021665-573A393D-1343-4FA6-AF5B-2637592A9916 Q27023490-2601B78F-8D0C-4983-80EF-88B36CABAB83 Q27028193-DD582B81-E072-410F-909E-D2DDD114145A Q28076823-7FD14CA3-0642-47BC-99FC-997B9780C9CD Q28080748-9E46A8F6-0418-47C4-A2ED-E8C9FDBFDF25 Q28084054-23AB5860-6841-4E19-B881-F45290176ED8 Q28258864-A065B4DD-1D98-4032-ABB1-E1C81E9CFB1E Q28727779-295B4080-8B3E-4EED-9EA8-02F54A11CC9A Q29540785-333295CE-842E-428E-A7A1-6604751EBC45 Q29620456-06E9A232-8536-44E1-A6D1-99185581C8D7 Q30251565-FC9F71F1-B7ED-402F-810A-305FF0A2F258 Q30404697-71B3009A-E755-4C17-A2CF-2A4A4D13DD4F Q30991322-030547D8-5609-4B7B-97A7-B577B9FCA74E Q33496141-05D09E44-FCAA-44ED-B2D6-217421C4CB1E Q33522476-6B3069A7-9F07-4B01-AF1E-2E03DE0B6A25 Q33587858-EDCC5E80-F61B-47BD-ACB9-00D2874E012F Q33602989-821DE030-FF12-4E5A-964F-64B6866783E2 Q33644457-5C680F6B-11BA-4B4B-B645-16F989BA15CC Q33690051-C52A9C7A-ED33-4A2F-90E8-15A9892400DD Q33765653-E3A13611-A404-4D24-BF07-BD0A045E7B90 Q33827740-D43A2C7C-72C1-4DB3-B31E-0AFA2D96431C Q33829997-5E9B87D7-70D4-4C0B-A3F2-771056718611 Q33835014-6BCD9338-A649-4846-A5EA-4A04C79D95A7 Q33882669-C2F9CC81-FC08-4DB0-9C75-9883681C2299 Q33965673-7994F8ED-0FD0-4A02-B89D-91A635CA6434 Q33984832-E863ABAC-E772-4885-AF5B-E12A9E6A09CF Q34032033-A3F2DDCF-B479-47BE-997D-FB9CA5BCCBC1 Q34035348-0D90B684-37EF-4B31-9B48-2328AEB94415 Q34062448-FB6E53B2-9FB4-48C3-B7B5-1396AFFEA5F7 Q34078663-3355E0C7-09BC-4C5F-9799-D805E9BF3CEC

P2860

Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response

http://www.wikidata.org/entity/Q37105363

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Reduced adipose tissue oxygena ...... without an angiogenic response

@en

Reduced adipose tissue oxygena ...... ithout an angiogenic response.

@nl

type

label

Reduced adipose tissue oxygena ...... without an angiogenic response

@en

Reduced adipose tissue oxygena ...... ithout an angiogenic response.

@nl

prefLabel

Reduced adipose tissue oxygena ...... without an angiogenic response

@en

Reduced adipose tissue oxygena ...... ithout an angiogenic response.

@nl

P1433

Q37105363-EBDB7878-373E-4F1A-B106-B845102DCB3F

P1476

Q37105363-A5FFA832-2E96-4EC6-83FA-1B671CF4A9D1

P2093

Q37105363-08E7E5E7-F377-4DDE-BDC5-A8265FD89970

Q37105363-187C42E0-AA80-4342-8E75-B536993AC94A

Q37105363-4F0F43C0-466D-46B4-B4FE-C4AA2122352B

Q37105363-5A0E1025-F061-4276-A334-4F8CDE01C7AC

Q37105363-5A1E8E0F-4940-4854-B30D-5086BBF77554

Q37105363-82D11422-3B85-40DA-8294-8AE5CFC154E7

Q37105363-B16E0288-A38F-41AE-930B-C81DE838BEC9

Q37105363-B98466EF-C394-43FB-ADBF-033B198BDA02

Q37105363-C2599CA4-D63E-4A73-ADBB-3E7A7A45A780

P2860

Q37105363-0E9470C3-AE96-433D-920F-63080B9F841C

Q37105363-1262322E-EC21-4736-9FFC-186D1DA918FD

Q37105363-1657BCFB-EDE8-4C8B-8417-61F66A5F5442

Q37105363-2CB3BFF2-A692-4668-9706-10082671B28E

Q37105363-2E369E00-00B0-4412-A12D-A041D3F51031

Q37105363-3B1AA48F-D673-4BC1-B7FD-1BDB775D1C07

Q37105363-40E05C56-F57E-4CF7-B03E-1FA1D7A412F7

Q37105363-447090C3-EA69-43AB-A91A-0DF5B137B201

Q37105363-45F4291C-2759-442C-BF6C-F3E86E7E532F

Q37105363-4AE9BDF5-2825-4D88-94D1-A4F9FE7A774D

P304

Q37105363-9A0AE7A2-F456-4EAC-AA21-E4D4C491A4B4

P31

Q37105363-530D3BE1-C525-466E-9EC7-6CFBD11CC90A

P356

Q37105363-394CFCF5-72AB-4396-AF9E-45BA19E9117C

P407

Q37105363-90CE0141-4298-4192-9BBF-A32EBB8A5D41

P433

Q37105363-E14BEDF9-5C8B-41EB-926D-EE9F873E5B80

P478

Q37105363-16A68203-7526-43B1-9829-5ED323C9E17C

P577

Q37105363-DBC73EBF-1413-4E72-A8EF-24645133CF68

P5875

Q37105363-AFEF92B5-CA02-4576-A589-28A0123B3395

P698

Q37105363-84EAFF8D-99C6-4CE9-8BB7-5813173A22D7

P921

Q37105363-238A5857-BF18-4DEE-BD80-09FBAA1183ED

Q37105363-31230857-DC8F-4EBF-8696-CF64E944F609

Q37105363-7646EE4F-BD4A-44A1-99AB-02502123E9E4

Q37105363-FE1EAF98-4368-4B0E-BEEA-464471E56B77

P932

Q37105363-F1F177C6-C6BD-4706-B82D-F2A03D2D5A1A

P356

P1433

P1476

Reduced adipose tissue oxygena ...... without an angiogenic response

@en

P2093

David H Burk

http://www.w3.org/2001/XMLSchema#string

David T Hymel

http://www.w3.org/2001/XMLSchema#string

Diana C Albarado

http://www.w3.org/2001/XMLSchema#string

Jennifer C Rood

http://www.w3.org/2001/XMLSchema#string

Laura E Roan

http://www.w3.org/2001/XMLSchema#string

Leanne M Redman

http://www.w3.org/2001/XMLSchema#string

Magdalena Pasarica

http://www.w3.org/2001/XMLSchema#string

Olga R Sereda

http://www.w3.org/2001/XMLSchema#string

Steven R Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes

Obesity is associated with macrophage accumulation in adipose tissue

Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays

Cloning of cell-specific secreted and surface proteins by subtractive antibody screening

Oxygen sensing by HIF hydroxylases

Regulation of the leptin content of obese human adipose tissue.

Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment

Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor.

P304

718-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB08-1098

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23655885

http://www.w3.org/2001/XMLSchema#string

P698

19074987

http://www.w3.org/2001/XMLSchema#string

P921

P932

2646071

http://www.w3.org/2001/XMLSchema#string